The interplay between inflammation, physical activity and metabolic syndrome in a remote male geriatric community in Southern Taiwan: The Tianliao Old People (TOP) study 03

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Chang, Chia Ling ^a   Lee, Po Tseng ^b,c   Chang, Wei Ting ^b,c   Chang, Chin Sung ^b,c   Chen, Jyh Hong ^b   Tsai, Liang Miin ^b   Wu, Chih Hsing ^b   Liu, Ping Yen ^b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Geriatric; Inflammation; Metabolic syndrome; Physical activity

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; GERIATRIC CARE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84885337843     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-60     Document Type: Article

References (43)

1. Banting lecture 1988. Role of insulin resistance in human disease. Reaven GM, Diabetes 1988 37 12 1595 1607 10.2337/diab.37.12.1595 3056758 (Pubitemid 19004941)
2. The metabolic syndrome. Eckel RH, Grundy SM, Zimmet PZ, Lancet 2005 365 9468 1415 1428 10.1016/S0140-6736(05)66378-7 15836891 (Pubitemid 40523737)
3. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. Grundy SM, J Am Coll Cardiol 2006 47 6 1093 1100 10.1016/j.jacc.2005.11.046 16545636
4. Abdominal obesity and metabolic syndrome. Despres JP, Lemieux I, Nature 2006 444 7121 881 887 10.1038/nature05488 17167477 (Pubitemid 46024995)
5. Intra-abdominal fat is a major determinant of the national cholesterol education program adult treatment panel III criteria for the metabolic syndrome. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE, Diabetes 2004 53 8 2087 2094 10.2337/diabetes.53.8.2087 15277390 (Pubitemid 38970759)
6. Metabolic syndrome: what are the risks for humans? Gupta A, Gupta V, Biosci Trends 2010 4 5 204 212 21068471
7. Interaction of physical activity level and metabolic syndrome among the adult Asian Indians living in Calcutta, India. Das M, Pal S, Ghosh A, J Nutr Health Aging 2012 16 6 539 543 10.1007/s12603-012-0019-y 22659993
8. Smoking, habitual tea drinking and metabolic syndrome in elderly Men living in rural community: the Tianliao Old People (TOP) study 02. Chang CS, Chang YF, Liu PY, Chen CY, Tsai YS, Wu CH, PLoS One 2012 7 6 38874 10.1371/journal.pone.0038874 22719971
9. Definition of metabolic syndrome: report of the national heart, lung, and blood institute/American heart association conference on scientific issues related to definition. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, Circulation 2004 109 3 433 438 10.1161/01.CIR.0000111245.75752.C6 14744958 (Pubitemid 38133916)
10. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Ridker PM, Wilson PW, Grundy SM, Circulation 2004 109 23 2818 2825 10.1161/01.CIR.0000132467.45278.59 15197153 (Pubitemid 38780294)
11. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC, BMJ 1996 312 7038 1061 1065 10.1136/bmj.312.7038.1061 8616412 (Pubitemid 26125131)
12. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland coronary prevention study. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N, Diabetes 2002 51 5 1596 1600 10.2337/diabetes.51.5.1596 11978661 (Pubitemid 34826630)
13. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Onat A, Can G, Hergenc G, Metabolism 2008 57 2 207 214 10.1016/j.metabol.2007.09.002 18191050
14. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM, JAMA 2001 286 3 327 334 10.1001/jama.286.3.327 11466099 (Pubitemid 32656163)
15. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT, Diabetologia 2004 47 8 1403 1410 15309290
16. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Pfutzner A, Forst T, Diabetes Technol Ther 2006 8 1 28 36 10.1089/dia.2006.8.28 16472048
17. Relation of C-reactive protein to abdominal adiposity. Brooks GC, Blaha MJ, Blumenthal RS, Am J Cardiol 2010 106 1 56 61 10.1016/j.amjcard.2010.02.017 20609648
18. Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. Araujo JP, Lourenco P, Azevedo A, Frioes F, Rocha-Goncalves F, Ferreira A, Bettencourt P, J Card Fail 2009 15 3 256 266 10.1016/j.cardfail.2008.10.030 19327628
19. Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women-a cross-racial validation. Hwang JJ, Li HY, Shieh GJ, Chien YF, Hua CH, Lin JW, Nutr Metab Cardiovasc Dis 2008 18 10 671 677 10.1016/j.numecd.2007.11.006 18378435
20. Association of C-Reactive protein, smoking and metabolic syndrome among the health check-up population. Chien KL, Hsu HC, Chen MF, Lee YT, Acta Cardiol Sin 2005 21 98 104
21. Exercise in the metabolic syndrome. Golbidi S, Mesdaghinia A, Laher I, Oxid Med Cell Longev 2012 2012 349710 22829955
22. Association between physical activity and markers of inflammation in a healthy elderly population. Geffken DF, Cushman M, Burke GL, Polak JF, Sakkinen PA, Tracy RP, Am J Epidemiol 2001 153 3 242 250 10.1093/aje/153.3.242 11157411 (Pubitemid 32958648)
23. Kaohsiung County Tianliao Township Household Registration Affairs [In Chinese] http://tianliaohouse.gov.tw/en/en-index.php
24. International physical activity questionnaire: 12-country reliability and validity. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. Med Sci Sports Exerc 2003 35 8 1381 1395 10.1249/01.MSS.0000078924.61453.FB 12900694 (Pubitemid 36936159)
25. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Circulation 2005 112 17 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
26. Standards of medical care in diabetes - 2010. American Diabetes Association, Diabetes Care 2010 33 Suppl 1 11 61 20042772
27. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, et al. Circulation 2003 107 3 499 511 10.1161/01.CIR.0000052939.59093.45 12551878 (Pubitemid 36158056)
28. Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European male ageing study. Tournoy J, Lee DM, Pendleton N, O'Neill TW, O'Connor DB, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, et al. Diabetes Metab Res Rev 2010 26 8 668 676 10.1002/dmrr.1144 21043047
29. Effect of physical activity on the prevalence of metabolic syndrome and left ventricular hypertrophy in apparently healthy adults. Dai DF, Hwang JJ, Chen CL, Chiang FT, Lin JL, Hsu KL, Tseng CD, Tseng YZ, J Formos Med Assoc 2010 109 10 716 724 10.1016/S0929-6646(10)60116-7 20970068
30. Physical activity in the Japan population: association with blood lipid levels and effects in reducing cardiovascular and all-cause mortality. Koba S, Tanaka H, Maruyama C, Tada N, Birou S, Teramoto T, Sasaki J, J Atheroscler Thromb 2011 18 10 833 845 10.5551/jat.8094 21946534
31. Effect of central obesity, low high-density lipoprotein cholesterol and C-reactive protein polymorphisms on C-reactive protein levels during treatment with Rosuvastatin (10 mg Daily). Hu M, Lee MH, Mak VW, Tomlinson B, Am J Cardiol 2010 106 11 1588 1593 10.1016/j.amjcard.2010.07.044 21094359
32. ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Yin K, Liao DF, Tang CK, Mol Med 2010 16 9-10 438 449 20485864
33. Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Zuliani G, Volpato S, Galvani M, Ble A, Bandinelli S, Corsi AM, Lauretani F, Maggio M, Guralnik JM, Fellin R, et al. Atherosclerosis 2009 203 2 626 632 10.1016/j.atherosclerosis. 2008.07.038 18845301
34. Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements. Ferland M, Despres JP, Tremblay A, Pinault S, Nadeau A, Moorjani S, Lupien PJ, Theriault G, Bouchard C, Br J Nutr 1989 61 2 139 148 10.1079/BJN19890104 2706220 (Pubitemid 19088482)
35. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ, Am J Cardiol 1994 73 7 460 468 10.1016/0002-9149(94)90676-9 8141087 (Pubitemid 24096208)
36. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Anand SS, Razak F, Yi Q, Davis B, Jacobs R, Vuksan V, Lonn E, Teo K, McQueen M, Yusuf S, Arterioscler Thromb Vasc Biol 2004 24 8 1509 1515 10.1161/01.ATV.0000135845.95890.4e 15205215 (Pubitemid 39050449)
37. Ethnic differences in cardiovascular risk factor burden among middle-aged women: study of women's health across the nation (SWAN). Matthews KA, Sowers MF, Derby CA, Stein E, Miracle-McMahill H, Crawford SL, Pasternak RC, Am Heart J 2005 149 6 1066 1073 10.1016/j.ahj.2004.08.027 15976790 (Pubitemid 40848152)
38. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X, J Am Coll Cardiol 2007 49 17 1798 1805 10.1016/j.jacc.2007.01.065 17466231 (Pubitemid 46629126)
39. Apolipoprotein AV variants do not affect C-reactive protein levels in caucasian males. Hubacek JA, Skodova Z, Lanska V, Stavek P, Adamkova V, Poledne R, Physiol Res 2005 54 6 687 689 15857156 (Pubitemid 43161736)
40. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Khor LL, Muhlestein JB, Carlquist JF, Horne BD, Bair TL, Maycock CA, Anderson JL, Am J Med 2004 117 9 657 664 10.1016/j.amjmed.2004.06.021 15501203 (Pubitemid 40288172)
41. The role of inflammation in age-related disease. Howcroft TK, Campisi J, Louis GB, Smith MT, Wise B, Wyss-Coray T, Augustine AD, McElhaney JE, Kohanski R, Sierra F, Aging (Albany NY) 2013 5 1 84 93 23474627
42. Gender differences in metabolic syndrome-a Key research issue? Iyer A, Kauter K, Brown L, Endocr Metab Immune Disord Drug Targets 2011 11 3 182 188 10.2174/187153011796429808 21831031
43. Urban and rural variation in clustering of metabolic syndrome components in the Thai population: results from the fourth national health examination survey 2009. Aekplakorn W, Kessomboon P, Sangthong R, Chariyalertsak S, Putwatana P, Inthawong R, Nitiyanant W, Taneepanichskul S, BMC Public Health 2011 11 1 854 10.1186/1471-2458-11-854 22074341